Form D/A — Andira Medicine Inc.
0000912282-26-001224 · filed Sep 4, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $1,619,844
- Reported amount sold
- $809,922
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Andira Medicine Inc.
- CIK
- 1916630
- Entity
- Corporation
- Jurisdiction
- BRITISH COLUMBIA, CANADA
- Year incorporated
- —
- Address
- 507-725 Marine Drive
North Vancouver, A1 V7M 0G2 - Phone
- 604-335-6348
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ethan Russo · DirectorNorth Vancouver, A1 Find on LinkedIn ↗
-
Michael Stuart Wall · DirectorNorth Vancouver, A1 Find on LinkedIn ↗
-
Ammad Shorbaji · Executive OfficerNorth Vancouver, A1 Find on LinkedIn ↗
-
Janette Lyons · Executive OfficerNorth Vancouver, A1 Find on LinkedIn ↗
-
Dana Lambert · DirectorNorth Vancouver, A1 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗